A Nanotechnology-Enabled Blood Test for Cancer Detection and Diagnosis

  • Enrollment

    This study is not currently enrolling.

  • Associated Conditions

  • Research Area

    Cancer Research

  • Principal Investigator

    Inoel Rivera

  • Sponsor

    AdventHealth CFD

The purpose of this study is to determine if a new blood test can be used for early detection of prostate and kidney cancer. The results of this study may be published in a peer-reviewed scientific journal by the research team.